Successful Use of Tocilizumab in a Patient with Coexisting Rheumatoid Arthritis and Ulcerative Colitis

Successful Use of Tocilizumab in a Patient with Coexisting Rheumatoid Arthritis and Ulcerative Colitis

Tocilizumab is an interleukin-6 receptor inhibitor licensed for moderate to severe rheumatoid arthritis (RA). We report a case of Tocilizumab monotherapy for severe active RA in a patient with coexisting ulcerative colitis (UC). The patient was intolerant to multiple disease-modifying drugs, so Toci...

Full description

Saved in:
Bibliographic Details
Main Authors: Matthew Chak Hin Szeto, Metin Devrim Yalçın, Abdul Khan, Andrzej Piotrowicz
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Case Reports in Immunology
Online Access:http://dx.doi.org/10.1155/2016/7562123
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items